New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
11:58 EDTAGN, VRXAllergan says DARPin would be worth less under Valeant ownership
In a regulatory filing, Allergan (AGN) says that competent development and execution is necessary to maximize ophthalmology drug DARPin's value. Allergan adds that Valeant (VRX) does not have the commitment or expertise to maximize the value of DARPin.
News For AGN;VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2015
11:39 EDTVRXPershing Square, Valeant, Allergan drop lawsuit over buyout
Subscribe for More Information
April 8, 2015
12:17 EDTVRXOn The Fly: Midday Wrap
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use